Cytokine Imbalance in Schizophrenia. From Research to Clinic: Potential Implications for Treatment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytokine Imbalance in Schizophrenia. From Research to Clinic: Potential Implications for Treatment
Authors
Keywords
-
Journal
Frontiers in Psychiatry
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-05
DOI
10.3389/fpsyt.2021.536257
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Altered structural connectivity and cytokine levels in Schizophrenia and Genetic high-risk individuals: Associations with disease states and vulnerability
- (2020) Yang Wang et al. SCHIZOPHRENIA RESEARCH
- Elevated levels of IL ‐18 associated with schizophrenia and first episode psychosis: A systematic review and meta‐analysis
- (2020) Ali Alamdar Shah Syed et al. Early Intervention in Psychiatry
- The association between serum levels of TNF-α and IL-6 in schizophrenic patients and their metabolic status – A case control study
- (2020) Jaśmina Arabska et al. JOURNAL OF NEUROIMMUNOLOGY
- The interactive effect of genetic polymorphisms of IL-10 and COMT on cognitive function in schizophrenia
- (2020) Jiesi Wang et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Association between the IL10 rs1800896 Polymorphism and Tardive Dyskinesia in Schizophrenia
- (2020) Kwang-Yeon Choi et al. Psychiatry Investigation
- Association Between SIRT1, Cytokines, and Metabolic Syndrome in Schizophrenia Patients With Olanzapine or Clozapine Monotherapy
- (2020) Xinyu Fang et al. Frontiers in Psychiatry
- The Missing Link: How Exosomes and miRNAs can Help in Bridging Psychiatry and Molecular Biology in the Context of Depression, Bipolar Disorder and Schizophrenia
- (2019) S. K. Gruzdev et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Effects of immunomodulatory drugs on depressive symptoms: A mega-analysis of randomized, placebo-controlled clinical trials in inflammatory disorders
- (2019) Gayle M. Wittenberg et al. MOLECULAR PSYCHIATRY
- Association of peripheral cytokine levels with cerebral structural abnormalities in schizophrenia
- (2019) Dongsheng Wu et al. BRAIN RESEARCH
- Cytokine Alterations in Schizophrenia: An Updated Review
- (2019) Sara Momtazmanesh et al. Frontiers in Psychiatry
- Tumor necrosis factor-alpha − 1031T/C polymorphism is associated with cognitive deficits in chronic schizophrenia patients versus healthy controls
- (2018) Mei Hong Xiu et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer’s Disease Pathology
- (2018) Marcella Reale et al. JOURNAL OF ALZHEIMERS DISEASE
- Profiling of Canonical and Non-Traditional Cytokine Levels in Interferon-β-Treated Relapsing–Remitting-Multiple Sclerosis Patients
- (2018) Chiara D’Angelo et al. Frontiers in Immunology
- Promoter Polymorphisms of TNF-α Gene (−1031 T/C, −863 C/A, −857 C/T, −308 G/A) as a Risk Factor for Schizophrenia
- (2018) Renata Suchanek-Raif et al. ARCHIVES OF MEDICAL RESEARCH
- Role of IL-6/RORC/IL-22 axis in driving Th17 pathway mediated immunopathogenesis of schizophrenia
- (2018) Manjula Subbanna et al. CYTOKINE
- Neuronal Enriched Extracellular Vesicle Proteins as Biomarkers for Brain Traumatic Injury
- (2018) Hanuma Kumar Karnati et al. JOURNAL OF NEUROTRAUMA
- Polymorphic Variants of TNFR2 Gene in Schizophrenia and Its Interaction with -308G/A TNF-α Gene Polymorphism
- (2018) Renata Suchanek-Raif et al. MEDIATORS OF INFLAMMATION
- Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depression
- (2018) Mandakh Bekhbat et al. PSYCHONEUROENDOCRINOLOGY
- Schizophrenia: A review of potential biomarkers
- (2017) Daniela Rodrigues-Amorim et al. JOURNAL OF PSYCHIATRIC RESEARCH
- A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Tocilizumab, An Interleukin-6 Receptor Antibody, For Residual Symptoms in Schizophrenia
- (2017) Ragy R Girgis et al. NEUROPSYCHOPHARMACOLOGY
- Immunopsychiatry: important facts
- (2017) G. M. Khandaker et al. PSYCHOLOGICAL MEDICINE
- Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies
- (2017) C F M G van Kesteren et al. Translational Psychiatry
- Plasma Extracellular Vesicles Enriched for Neuronal Origin: A Potential Window into Brain Pathologic Processes
- (2017) Maja Mustapic et al. Frontiers in Neuroscience
- Associations between SNPs and immune-related circulating proteins in schizophrenia
- (2017) Man K. Chan et al. Scientific Reports
- Sirukumab: A Potential Treatment for Mood Disorders?
- (2016) Aileen J. Zhou et al. ADVANCES IN THERAPY
- The value of interleukin 6 as a peripheral diagnostic marker in schizophrenia
- (2016) Kayla A. Chase et al. BMC Psychiatry
- Association of the IFN-γ (+874A/T) Genetic Polymorphism with Paranoid Schizophrenia in Tunisian Population
- (2016) Achraf Jemli et al. IMMUNOLOGICAL INVESTIGATIONS
- An Open-Label, Pilot Trial of Adjunctive Tocilizumab in Schizophrenia
- (2016) Brian J. Miller et al. JOURNAL OF CLINICAL PSYCHIATRY
- Altered serum levels of interleukin-3 in first-episode drug-naive and chronic medicated schizophrenia
- (2016) Yin Yang Fu et al. SCHIZOPHRENIA RESEARCH
- Inflammation and Elevation of Interleukin-12p40 in Patients with Schizophrenia
- (2016) Nora Bedrossian et al. Frontiers in Molecular Neuroscience
- Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation
- (2015) Jeremy F. Weinberger et al. BRAIN BEHAVIOR AND IMMUNITY
- Clozapine Regulates Cytokines, T-cell Subsets and Immunoglobulins Serum Levels in MK-801-Evoked Schizophrenia Rat
- (2015) Jun Li et al. International Journal of Pharmacology
- Adaptive Immunity in Schizophrenia: Functional Implications of T Cells in the Etiology, Course and Treatment
- (2015) Monojit Debnath Journal of Neuroimmune Pharmacology
- Increased IL-3 serum levels in chronic patients with schizophrenia: Associated with psychopathology
- (2015) Mei Hong Xiu et al. PSYCHIATRY RESEARCH
- Increased Interleukin-17 and decreased BAFF serum levels in drug-free acute schizophrenia
- (2015) Yousri El Kissi et al. PSYCHIATRY RESEARCH
- Association study of functional polymorphisms in interleukins and interleukin receptors genes: IL1A, IL1B, IL1RN, IL6, IL6R, IL10, IL10RA and TGFB1 in schizophrenia in Polish population
- (2015) Pawel Kapelski et al. SCHIZOPHRENIA RESEARCH
- Interleukin-6: the missing element of the neurocognitive deterioration in schizophrenia? The focus on genetic underpinnings, cognitive impairment and clinical manifestation
- (2015) Dorota Frydecka et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Effects of Risperidone on Cytokine Profile in Drug-Naive First-Episode Psychosis
- (2015) C. Noto et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Adjunctive Recombinant Human Interferon Gamma-1b for Treatment-Resistant Schizophrenia in 2 Patients
- (2014) Lena Grüber et al. JOURNAL OF CLINICAL PSYCHIATRY
- Activation of Th17 cells in drug naïve, first episode schizophrenia
- (2014) Minli Ding et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Chronic schizophrenia is associated with over-expression of the interleukin-2 receptor gamma gene
- (2014) Hovsep Ghazaryan et al. PSYCHIATRY RESEARCH
- Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment
- (2014) Lot de Witte et al. SCHIZOPHRENIA RESEARCH
- Cytokine function in medication-naive first episode psychosis: A systematic review and meta-analysis
- (2014) Rachel Upthegrove et al. SCHIZOPHRENIA RESEARCH
- Effects of Antipsychotics on the Inflammatory Response System of Patients with Schizophrenia in Peripheral Blood Mononuclear Cell Cultures
- (2014) Mamun Al-Amin et al. Clinical Psychopharmacology and Neuroscience
- Phase 1, randomized, double-blind, placebo-controlled, multiple intravenous, dose-ascending study of sirukumab in cutaneous or systemic lupus erythematosus
- (2013) Jacek C. Szepietowski et al. ARTHRITIS AND RHEUMATISM
- Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression
- (2013) Divya Mehta et al. BRAIN BEHAVIOR AND IMMUNITY
- Interleukin 1 beta gene and risk of schizophrenia: detailed case-control and family-based studies and an updated meta-analysis
- (2013) Masako Shibuya et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Regulation of macrophage immune responses by antipsychotic drugs
- (2013) Mao-Liang Chen et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Association of Interleukin 2 (IL-2), Interleukin 6 (IL-6), and TNF-alpha (TNFα) Gene Polymorphisms With Paranoid Schizophrenia in a Polish Population
- (2013) Monika Paul-Samojedny et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder
- (2013) Daimei Sasayama et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis
- (2013) LANCET
- Genetic variants in transforming growth factor-β gene (TGFB1) affect susceptibility to schizophrenia
- (2013) Dorota Frydecka et al. MOLECULAR BIOLOGY REPORTS
- The Interaction of Polymorphisms of IL10 and DBH Was Associated with General Symptoms of PANSS with TD in Chinese Han Schizophrenic Patients
- (2013) Hongqiang Sun et al. PLoS One
- Increased serum interleukin-6 levels in early stages of psychosis: Associations with at-risk mental states and the severity of psychotic symptoms
- (2013) Alexander Stojanovic et al. PSYCHONEUROENDOCRINOLOGY
- Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first-episode schizophrenia
- (2013) Xueqin Song et al. PSYCHOPHARMACOLOGY
- Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update
- (2013) I. E. Sommer et al. SCHIZOPHRENIA BULLETIN
- Differential correlations between inflammatory cytokines and psychopathology in veterans with schizophrenia: Potential role for IL-17 pathway
- (2013) Dimitre H. Dimitrov et al. SCHIZOPHRENIA RESEARCH
- Antipsychotics can modulate the cytokine profile in schizophrenia: Attenuation of the type-2 inflammatory response
- (2013) Milica Borovcanin et al. SCHIZOPHRENIA RESEARCH
- Relationship between Inflammatory Mediators, A? Levels and ApoE Genotype in Alzheimer Disease
- (2012) M. Reale et al. Current Alzheimer Research
- Lack of association of IL-6 (−174 G>C) and TNF-α (−238 G>A) variants with paranoid schizophrenia in Indian Bengalee population
- (2012) Monojit Debnath et al. CYTOKINE
- The Neuroprotective Functions of Transforming Growth Factor Beta Proteins
- (2012) Arpád Dobolyi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Relation between Pro-inflammatory Cytokines and Acetylcholine Levels in Relapsing-Remitting Multiple Sclerosis Patients
- (2012) Marcella Reale et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Elevated interleukin-18 serum levels in chronic schizophrenia: Association with psychopathology
- (2012) Mei Hong Xiu et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse
- (2012) Milica Borovcanin et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity
- (2012) Mariana Pedrini et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Haplotypes in the expression quantitative trait locus of interleukin-1β gene are associated with schizophrenia
- (2012) Masakuni Yoshida et al. SCHIZOPHRENIA RESEARCH
- Interleukin-6 promoter polymorphism and plasma levels in patients with schizophrenia
- (2012) R. Zakharyan et al. TISSUE ANTIGENS
- A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
- (2012) Charles L. Raison et al. JAMA Psychiatry
- Possible association between Interleukin-1beta gene and schizophrenia in a Japanese population
- (2011) Daimei Sasayama et al. Behavioral and Brain Functions
- Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
- (2011) Brian J. Miller et al. BIOLOGICAL PSYCHIATRY
- Cytokine release from innate immune cells: association with diverse membrane trafficking pathways
- (2011) P. Lacy et al. BLOOD
- Dysregulation of chemo-cytokine production in schizophrenic patients versus healthy controls
- (2011) Marcella Reale et al. BMC NEUROSCIENCE
- Association Between Promoter Variants of Interleukin-18 and Schizophrenia in a Han Chinese Population
- (2011) Jinnan Liu et al. DNA AND CELL BIOLOGY
- An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces
- (2011) Roosmarijn C. Drexhage et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Impact of antipsychotics on cytokine production in-vitro
- (2011) Hubertus Himmerich et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Inflammatory processes in schizophrenia: A promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond
- (2011) Urs Meyer et al. PHARMACOLOGY & THERAPEUTICS
- Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance
- (2011) Mauricio Kunz et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Cognition in schizophrenia: core psychological and neural mechanisms
- (2011) Deanna M. Barch et al. TRENDS IN COGNITIVE SCIENCES
- Interferon-Regulatory Factor 4 Is Essential for the Developmental Program of T Helper 9 Cells
- (2010) Valérie Staudt et al. IMMUNITY
- Functional Polymorphism in the Interleukin-6 and Interleukin-10 Genes in Patients with Paranoid Schizophrenia —A Case-Control Study
- (2010) Monika Paul-Samojedny et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Interleukin 18 in the CNS
- (2010) Silvia Alboni et al. Journal of Neuroinflammation
- Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial
- (2010) Richard G. Langley et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Chronic Expression of Transforming Growth Factor-Beta Enhances Adult Neurogenesis
- (2010) Patricia Mathieu et al. NEUROIMMUNOMODULATION
- Pathways for Cytokine Secretion
- (2010) Amanda C. Stanley et al. PHYSIOLOGY
- Analysis of peripheral immune activation in schizophrenia using quantitative reverse-transcription polymerase chain reaction (RT-PCR)
- (2010) Oliver Freudenreich et al. PSYCHIATRY RESEARCH
- Convergent Evidence Shows a Positive Association of Interleukin-1 Gene Complex Locus with Susceptibility to Schizophrenia in the Caucasian population
- (2010) Mingqing Xu et al. SCHIZOPHRENIA RESEARCH
- Common variants conferring risk of schizophrenia: A pathway analysis of GWAS data
- (2010) Peilin Jia et al. SCHIZOPHRENIA RESEARCH
- Persistently increased serum soluble interleukin-2 receptors in continuously ill patients with schizophrenia
- (2009) Catherine Bresee et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Activation of brain interleukin-1β in schizophrenia
- (2009) J Söderlund et al. MOLECULAR PSYCHIATRY
- Genetic variants of IL-6 and its receptor are not associated with schizophrenia in Taiwan
- (2009) Yu-Li Liu et al. NEUROSCIENCE LETTERS
- A Discriminating Messenger RNA Signature for Bipolar Disorder Formed by an Aberrant Expression of Inflammatory Genes in Monocytes
- (2008) Roos C. Padmos et al. ARCHIVES OF GENERAL PSYCHIATRY
- Interleukin-6 Mediates the Increase in NADPH-Oxidase in the Ketamine Model of Schizophrenia
- (2008) M. M. Behrens et al. JOURNAL OF NEUROSCIENCE
- The value of interleukin-12B (p40) gene promoter polymorphism in patients with schizophrenia in a region of East Turkey
- (2008) Ulku Ozbey et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia
- (2008) Sinead M. O'Brien et al. PSYCHIATRY RESEARCH
- Negative Symptoms in Schizophrenia: Avolition and Occam's Razor
- (2008) G. Foussias et al. SCHIZOPHRENIA BULLETIN
- Association between interleukin-6 receptor polymorphism and patients with schizophrenia
- (2008) S SUN et al. SCHIZOPHRENIA RESEARCH
- Patients with schizophrenia show raised serum levels of the pro-inflammatory chemokine CCL2: Association with the metabolic syndrome in patients?
- (2008) R DREXHAGE et al. SCHIZOPHRENIA RESEARCH
- Comprehensive evaluation of positional candidates in the IL-18 pathway reveals suggestive associations with schizophrenia and herpes virus seropositivity
- (2007) Brian H. Shirts et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review
- (2007) Stéphane Potvin et al. BIOLOGICAL PSYCHIATRY
- TGFBR2 gene expression and genetic association with schizophrenia
- (2007) Shusuke Numata et al. JOURNAL OF PSYCHIATRIC RESEARCH
- From inflammation to sickness and depression: when the immune system subjugates the brain
- (2007) Robert Dantzer et al. NATURE REVIEWS NEUROSCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now